Correlation Between JPMorgan Chase and VentriPoint Diagnostics

Can any of the company-specific risk be diversified away by investing in both JPMorgan Chase and VentriPoint Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining JPMorgan Chase and VentriPoint Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between JPMorgan Chase Co and VentriPoint Diagnostics, you can compare the effects of market volatilities on JPMorgan Chase and VentriPoint Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in JPMorgan Chase with a short position of VentriPoint Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of JPMorgan Chase and VentriPoint Diagnostics.

Diversification Opportunities for JPMorgan Chase and VentriPoint Diagnostics

-0.75

Correlation Coefficient

JPMorgan Chase  VentriPoint Diagnostics

Pay attention - limited upside

The 3 months correlation between JPMorgan and VentriPoint is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding JPMorgan Chase Co and VentriPoint Diagnostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VentriPoint Diagnostics and JPMorgan Chase is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on JPMorgan Chase Co are associated (or correlated) with VentriPoint Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VentriPoint Diagnostics has no effect on the direction of JPMorgan Chase i.e., JPMorgan Chase and VentriPoint Diagnostics go up and down completely randomly.

Pair Corralation between JPMorgan Chase and VentriPoint Diagnostics

Assuming the 90 days trading horizon JPMorgan Chase Co is expected to under-perform the VentriPoint Diagnostics. But the stock apears to be less risky and, when comparing its historical volatility, JPMorgan Chase Co is 5.85 times less risky than VentriPoint Diagnostics. The stock trades about -0.08 of its potential returns per unit of risk. The VentriPoint Diagnostics is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  10.00  in VentriPoint Diagnostics on October 7, 2024 and sell it today you would earn a total of  1.00  from holding VentriPoint Diagnostics or generate 10.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

JPMorgan Chase Co  vs.  VentriPoint Diagnostics

JPMorgan Chase

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in JPMorgan Chase Co are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain basic indicators, JPMorgan Chase displayed solid returns over the last few months and may actually be approaching a breakup point.

VentriPoint Diagnostics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days VentriPoint Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in February 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with JPMorgan Chase and VentriPoint Diagnostics

The main advantage of trading using opposite JPMorgan Chase and VentriPoint Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if JPMorgan Chase position performs unexpectedly, VentriPoint Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VentriPoint Diagnostics will offset losses from the drop in VentriPoint Diagnostics' long position.

The idea behind JPMorgan Chase Co and VentriPoint Diagnostics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.